In response to the FDA’s recent public health advisory citing potential dangers of overusing Erythropoiesis-Stimulating Agents (ESAs), the Renal Physicians Association (RPA) urges caution among its doctors and patients when considering any changes to anemia management regimens.
The risk of Sudden Infant Death Syndrome (SIDS), the third leading cause of infant death, may be lowered through the use of a pacifier. According to an article in Nursing for Women?s Health, neonatal health care practitioners should counsel new parents on the potential benefits of using a pacifier.
Researchers at the University of Pennsylvania’s School of Medicine have discovered that common inhaled anesthetics increase the number of amyloid plaques in the brains of animals, which might accelerate the onset of neurodegenerative diseases like Alzheimer’s.
Improving access to and utilization of the healthcare system may benefit African-American prostate cancer patients more than educational or motivational interventions, according to a new study.
Human embryonic stem cells (hESCs) hold great promise forbenefiting degenerative diseases, and do so by invoking multiplemechanisms. Such cells can be grown in a manner compatible with clinicaluse (i.e., without animal feeder layers) and even without the need forimmunosuppression.
There is no evidence that walk-in centers shorten waiting times to see a general practitioner, say researchers in a BMJ study published online today.
Researchers from Harvard Medical School, Boston, have found that most individuals with acute myeloid leukemia (AML) inappropriately express a protein known as CDX2 in their leukemic cells.
The first detailed images of an elusive drug target on the outer wall of bacteria may provide scientists with enough new information to aid design of novel antibiotics. The drugs are much needed to treat deadly infections initiated by Staphylococcus aureus and other bacterial pathogens.
Research in Wales has demonstrated that the Incredible Years parenting programme, an evidence-based programme developed at the University of Washington, Seattle, is very effective in reducing the likelihood of children going on to develop behavioural problems in the UK.
An article published in ‘The Lancet’ by researchers from the Menzies School of Health Research (MSHR) in Darwin has revealed a breakthrough in the battle to treat Malaria ? a disease which effects 40 per cent of the worlds population.